Patent Licensing Agreement

A patent licensing agreement is a contract in which the patent owner (licensor) grants the licensee the right to make, use, sell, import, or offer for sale a patented invention, in exchange for compensation (royalties or other consideration) and subject to specified terms and conditions. The license does not transfer ownership of the patent — the licensor retains title. A patent license must be written to be enforceable under 35 U.S.C. § 261 (assignments); while licenses don't have the same strict recording requirements as assignments, a written agreement is standard practice and required in most jurisdictions for formal enforcement. Key threshold choices in structuring a patent license: (1) exclusive vs. non-exclusive; (2) field of use (unrestricted vs. limited to specific markets/applications); (3) territory (worldwide vs. specific countries); (4) term (life of the patent vs. shorter); (5) royalty structure (running royalty vs. lump sum vs. milestone-based); (6) sublicensing rights (yes/no/with-approval).

Patent licenses use several royalty structures depending on the nature of the invention and the parties' relative bargaining positions: (1) RUNNING ROYALTY — a percentage of the licensee's net sales or revenues from products embodying the patent; e.g., '4% of net sales of licensed products'; aligns incentives (licensor participates in the licensee's commercial success); requires audit rights to verify sales figures; the royalty base and rate are heavily negotiated; (2) LUMP-SUM PAYMENT — a one-time upfront payment for the full license; simple to administer; licensor bears all risk if the licensed product succeeds beyond expectations; (3) MILESTONE PAYMENTS — payments triggered by specific events, such as regulatory approval, first commercial sale, or hitting a revenue threshold; common in pharma/biotech where commercialization involves significant development risk; (4) MINIMUM ROYALTY / MINIMUM ANNUAL ROYALTY (MAR) — a floor on annual royalty payments, regardless of actual sales; protects licensor from a licensee that sits on the license without commercializing; (5) UPFRONT LICENSE FEE plus running royalty — a common hybrid; the upfront fee covers initial exclusivity or technology transfer; running royalties cover ongoing commercial use; (6) EQUITY — particularly for early-stage startups; the licensor receives equity in the licensee instead of or in addition to cash royalties.

An EXCLUSIVE LICENSE grants rights to only one licensee in a defined field and territory — the licensor cannot grant the same rights to anyone else during the license term. Variants: (a) FULLY EXCLUSIVE: even the patent owner itself cannot practice the patent in the field (rare); (b) EXCLUSIVE with RETAINED RIGHTS: the licensor retains the right to practice the patent itself (common in university licenses); (c) FIELD-LIMITED EXCLUSIVE: exclusive only in a specific field or territory, with other fields/territories available for other licensees. An EXCLUSIVE LICENSEE with 'all substantial rights' may have standing to sue for infringement independently (Morrow v. Microsoft Corp.). A NON-EXCLUSIVE LICENSE grants the licensee the right to practice the patent, but the licensor can simultaneously grant the same rights to many other licensees and can practice the patent itself. Non-exclusive licenses: generate less royalty per licensee but can be scaled to many licensees; licensee typically has no standing to sue infringers without joining the patent owner; appropriate when the invention has wide applicability and the patent owner wants to maximize access. KEY DISTINCTION: exclusivity has significant value — exclusive licensees pay substantially higher royalties than non-exclusive licensees for the same rights.

A field-of-use restriction limits the licensee's right to use the patent to a specified field of use — a market, application, technology area, or customer category. Example: a patent on a chemical compound might be licensed to Company A for pharmaceutical use and to Company B for agricultural use — each gets an exclusive field-of-use license in their respective market. GENERAL INSTRUMENT CORP. v. UNITED STATES ITC (Fed. Cir.): field-of-use licenses are valid and enforceable; a licensee that uses the patent outside its licensed field of use infringes the patent. PURPOSE: allows the patent owner to maximize licensing revenue by separately licensing each market; allows licensees to get exclusivity in their target market without paying for rights they don't need; common in university tech transfer. ROYALTY BASE AND FIELD: when a product is sold in a licensed field and an unlicensed field, the royalty base must be carefully defined to apply only to sales within the licensed field. GRANTS: a common field-of-use license provision is: '[Licensor] hereby grants to [Licensee] an exclusive license under the Licensed Patents to make, use, sell, offer for sale, and import Licensed Products in the Field of Use in the Territory.' The 'Field of Use' definition is then a separately defined term, often the most heavily negotiated definition in the agreement.

AUDIT RIGHTS: patent licenses with running royalties almost always include audit rights: (1) BOOKS AND RECORDS — licensee must maintain accurate records of sales of licensed products for a specified period (typically 3–5 years); (2) AUDIT RIGHT — licensor has the right (typically once per year, on reasonable notice) to have an independent certified public accountant audit the licensee's books to verify royalty payments; (3) UNDER-REPORTING REMEDY — if the audit reveals under-reporting above a threshold (typically 5%), the licensee pays the audit cost plus the shortfall plus interest; if under a threshold, each party pays their own costs; (4) CONFIDENTIALITY — audit results are confidential (the auditor typically signs an NDA). TERMINATION PROVISIONS: (1) TERMINATION FOR BREACH — either party can terminate if the other materially breaches and fails to cure within a specified period (typically 30–60 days after written notice); (2) TERMINATION FOR CONVENIENCE — sometimes granted to the licensee (the stronger party in many commercial licenses); (3) TERMINATION FOR INSOLVENCY — upon bankruptcy or insolvency of either party; note: 11 U.S.C. § 365(n) protects licensees in the licensor's bankruptcy — the licensee can elect to retain its rights by continuing to pay royalties; (4) EFFECTS OF TERMINATION — all rights revert to licensor; licensee may sell off existing inventory for a 'selloff period' (typically 6 months); sublicenses may or may not survive depending on the agreement.